Glucocorticoid induced expression of connective tissue growth factor contributes to lactogenic differentiation of mouse mammary epithelial cells

Journal of Cellular Physiology

Volumn 214, Issue 1, 2008, Pages 38-46

  Wang, Weihan ^a   Morrison, Bethanie ^a   Galbaugh, Traci ^a   Jose, Cynthia C ^a   Kenney, Nicholas ^b   Cutler, Mary Lou ^a,c  

^a Uniformed Services University of the Health Sciences   (United States)

^b HAMPTON UNIVERSITY   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; DEXAMETHASONE; GLUCOCORTICOID;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; LACTOGENIC DIFFERENTIATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TISSUE DIFFERENTIATION; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; DEXAMETHASONE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GREEN FLUORESCENT PROTEINS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED BALB C; PREGNANCY; PROLACTIN;

MUS;

EID: 36649025092     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21159     Document Type: Article

References (65)

1. Akhtar N, Streuli CH. 2006. Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia. J Cell Biol 173:781-793.
2. Bailey JP, Nieport KM, Herbst MP, Srivastava S, Serra RA, Horseman ND. 2004. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.Mol Endocrinol 18:1171-1184.
3. Ball R, Friis R, Schonenberger C, Doppler W, Groner B. 1988. Prolactin regulation of a β-casein gene expression and a cytosolic 1 20kD protein in a cloned mouse mammary epithelial cell line. EMBO J 7:2089-2095.
4. Ball DK, Rachfal AW, Kemper SA, Brigstock DR. 2003. The heparin-binding 10 kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion. J Endocrinol 176:R1-7.
5. Balogh GA, Heulings R, Mailo DA, Russo PA, Sheriff F, Russo IH, Moral R, Russo J. 2006. Genomic signature induced by pregnancy In the human breast. Int J Oncol 28:399-410.
6. Brigstock DR. 2003. The CCN family: A new stimulus package. J Endocrinol 178:169-175.
7. Brigstock DR, Steffen CL, Kim GY, Vegunta RK, Diehl JR, Harding PA. 1997. Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J Biol Chem 272:20275-20282.
8. Cerrito MG, Galbaugh T, Wang W, Chopp T, Salomon D, Cutler ML. 2004. Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway. J Cell Physiol 201:244-258.
9. Clarkson RW, Watson CJ. 2003. Microarray analysis of the involution switch. J Mammary Gland Biol Neoplasia 8:309-319.
10. Croci S, Landuzzi L, Astolfi A, Nicoletti G, Rosolen A, Sartori F, Folio MY, Oliver N, De Giovanni C, Nanni P, Lollini PL. 2004. Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res 64:1730-1736.
11. Dammeier J, Beer HD, Brauchle M, Werner S. 1998. Dexamethasone is a novel potent inducer of connective tissue growth factor expression. Implications for glucocorticoid therapy. J Biol Chem 273:18185-18190.]
12. Danielson K, Oborn C, Durham E, Butel J, Medina D. 1984. Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci USA 81:3756-3760.
13. Desrivieres S, Prinz T, Castro-Palomino Laria N, Meyer M, Boehm G, Bauer U, Schafer J, Neumann T, Shemanko C, Groner B. 2003. Comparative proteomic analysis of proliferating and functionally differentiated mammary epithelial cells. Mol Cell Proteomics 2:1039-1054.
14. Faraci-Orf E, McFadden C, Vogel WF. 2006. DDR1 signaling is essential to sustain Stat5 function during lactogenesis. J Cell Biochem 97:109-121.
15. Faraldo MM, Deugnier MA, Tlouzeau S, Thiery JP, Glukhova MA. 2002. Perturbation of beta1-integrin function in involuting mammary gland results in premature dedifferentiation of secretory epithelial cells. Mol Biol Cell 13:3521-3531.
16. Fata JE, Werb Z, Bissell MJ. 2004. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 6:1-11.
17. Frazier KS, Grotendorst GR. 1997. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol 29:153-161.
18. Galbaugh T, Cerrito MG, Jose CC, Cutler ML. 2006. EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HCI 1 cell lactogenic differentiation. BMC Cell Biol 7:34.
19. Gao R, Brigstock DR. 2003. Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 27:214-220.
20. Gao R, Brigstock DR. 2004. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparin sulfate proteoglycan. J Biol Chem 279:8848-8855.
21. Gao R, Brigstock DR. 2006. A novel integrin alpha5beta1 binding domain in module 4 of connective tissue growth factor (CCN2/CTGF) promotes adhesion and migration of activated pancreatic stellate cells. Gut 55:856-862.
22. Grotendorst GR. 1997. Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8:171-179.
23. Grotendorst GR, Duncan MR. 2005. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 19:729-738.
24. Grotendorst GR, Rahmanie H, Duncan MR. 2004. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 18:469-479.
25. Higgins DF, Biju MP, Akai Y, Wutz A, Johnson RS, Haase VH. 2004. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 287:F1223-F1232.
26. Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Luscher TF, Fujii T. 1999. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem 274:37461-37466.
27. Hoshijima M, Hattori T, Inoue M, Araki D, Hanagata H, Miyauchi A, Takigawa M. 2006. CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett 580:1376-1382.
28. Humphreys R, Rosen J. 1997. Stably transfected HCI 1 cells provide and in vitro and in vivo model system for studying Wnt gene expression. Cell Growth Differ 8:839-849.
29. Hynes N, Taverna D, Harwerth I, Ciardiello F, Salomon D, Yamamoto T, Groner B. 1990. Epidermal growth factor, but not c-erb-2, activation prevents lactogenic hormone induction of β-casein gene in mouse mammary epithelial cell line. Mol Cell Biol 10:4027-4034.
30. Itasaki N, Jones CM, Mercurio S, Rowe A, Domingos PM, Smith JC, Krumlauf R. 2003. Wise, a context-dependent activator and inhibitor of Wnt signalling. Development 130:4295-4305.
31. Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM. 2003. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779-2791.
32. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE. 2004. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 11:781-791.
33. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J. 2003. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537-549.
34. Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD. 2002. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene 21:3172-3180.
35. Kleer CG, Zhang Y, Pan Q, Merajver SD. 2004. WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. Neoplasia 6:179-185.
36. Klinowska TC, Broomhead G, Streuli CH. 1996. Requirement for beta 1 integrins in the development of mouse mammary gland. Biochem Soc Trans 24:349S.
37. Klinowska TC, Soriano JV, Edwards GM, Oliver JM, Valentijn AJ, Montesano R, Streuli CH. 1999. Laminin and beta 1 integrins are crucial for normal mammary gland development in the mouse. Dev Biol 215:13-32.
38. Kondo S, Kubota S, Shimo T, Nishida T, Yosimichi G, Eguchi T, Sugahara T, Takigawa M. 2002. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23:769-776.
39. Kondo S, Kubota S, Mukudai Y, Moritani N, Nishida T, Matsushita H, Matsumoto S, Sugahara T, Takigawa M. 2006. Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3′-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene 25:1099-1110.
40. Kondo S, Tanaka N, Kubota S, Mukudai Y, Yosimichi G, Sugahara T, Takigawa M. 2006. Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells. Mol Cancer Ther 5:129-137.
41. Kubota S, Moritani NH, Kawaki H, Mimura H, Minato M, Takigawa M. 2003. Transcriptional induction of connective tissue growth factor/hypertrophic chondrocyte-specific 24 gene by dexamethasone in human chondrocyte cells. Bone 33:694-702.
42. Li ML, Aggeler J, Farson DA, Hatier C, Hassell J, Bissell MJ. 1987. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc Natl Acad Sci USA 84:136-140.
43. Li N, Zhang Y, Naylor MJ, Schatzmann F, Maurer F, Wintermantel T, Schuetz G, Mueller U, Streuli CH, Hynes NE. 2005. Beta 1 integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoli. EMBO J 24:1942-1953.
44. Marte B, Jeschke M, Grause-Porta D, Taverna D, Hofer P, Groner B, Yarden Y, Hynes N. 1995. Neu differentiaiton factor/heregulin modulates growth and differentitaion of HCI 1 mammary epithelial cells. Mol Endocrinol 9:14-23.
45. Medina D. 1996. The mammary gland: A unique organ for the study of development and tumorigenesis. J Mammary Gland Biol Neoplasia 1:5-19.
46. Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC. 2004. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131:2137-2147.
47. Merlo G, Grause-Porta D, Cella N, Marte B, Taverna D, Hynes N. 1996. Growth, differentiation and survival of HCI 1 mammary epithelial cells: Diverse effects of receptor tyrosine kinase-activating peptide growth factors. Eur J Cell Biol 70:97-105.
48. Mieth M, Boehmer FD, Ball R, Groner B, Grosse R. 1990. Transforming growth factor-beta inhibits lactogenic hormone induction of beta-casein expression in HCI 1 mouse mammary epithelial cells. Growth Factors 4:9-15.
49. Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J. 2005. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115:44-55.
50. Muschler J, Lochter A, Roskelley CD, Yurchenco P, Bissell MJ. 1999. Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells. Mol Biol Cell 10:2817-2828.
51. Naylor MJ, Li N, Cheung J, Lowe ET, Lambert E, Marlow R, Wang P, Schatzmann F, Wintermantel T, Schuetz G, Clarke AR, Mueller U, Hynes NE, Streuli CH. 2005. Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J Cell Biol 171:717-728.
52. Okada H, Kikuta T, Inoue T, Kanno Y, Ban S, Sugaya T, Takigawa M, Suzuki H. 2006. Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner. Am J Pathol 168:737-747.
53. Perbal B. 2004. CCN proteins: Multifunctional signalling regulators. Lancet 363:62-64.
54. Rageh MA, Moussad EE, Wilson AK, Brigstock DR. 2001. Steroidal regulation of connective tissue growth factor (CCN2; CTGF) synthesis in the mouse uterus. Mol Pathol 54:338-346.
55. Roestenberg P, van Nieuwenhoven FA, Wieten L, Boer P, Diekman T, Tiller AM, Wiersinga WM, Oliver N, Usinger W, Weitz S, Schlingemann RO, Goldschmeding R. 2004. Connective tissue growth factor is increased in plasma of type I diabetic patients with nephropathy. Diabetes Care 27:1164-1170.
56. Roskelley CD, Srebrow A, Bissell MJ. 1995. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opin Cell Biol 7:736-747.
57. Shimo T, Kubota S, Kondo S, Nakanishi T, Sasaki A, Mese H, Matsumura T, Takigawa M. 2001. Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett 174:57-64.
58. Smith GH. 1996. Experimental mammary epithelial morphogenesis in an in vivo model: Evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res Treat 39:21-31.
59. Streuli CH, Bailey N, Bissell MJ. 1991. Control of mammary epithelial differentiation: Basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol 115:1383-1395.
60. Streuli CH, Schmidhauser C, Bailey N, Yurchenco P, Skubitz AP, Roskelley C, Bissell MJ. 1995. Laminin mediates tissue-specific gene expression in mammary epithelia. J Cell Biol 129:591-603.
61. Taverna D, Groner B, Hynes N. 1991. Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-ErbB receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation. Cell Growth Differ 2:145-154.
62. Troester MA, Hoadley KA, Sorlie T, Herbert BS, Borresen-Dale AL, Lonning PE, Shay JW, Kaufmann WK, Perou CM. 2004. Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res 64:4218-4226.
63. van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD. 1999. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5:2511-2519.
64. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP. 2001. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61:8917-8923.
65. Zhang Y, Pan Q, Zhong H, Merajver SD, Kleer CG. 2005. Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Res 7:R1080-R1089.